PARSABIV

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Israel, Japan, Lithuania, Netherlands, Poland, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug PARSABIV contains one active pharmaceutical ingredient (API):

1 Etelcalcetide
UNII 72PT5993DU - ETELCALCETIDE HYDROCHLORIDE

Etelcalcetide is a synthetic peptide calcimimetic agent which reduces PTH secretion through binding and activation of the calcium-sensing receptor. Etelcalcetide is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy.

Read about Etelcalcetide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PARSABIV Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H05BX04 H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BX Other anti-parathyroid agents
Discover more medicines within H05BX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1733217, 1733228, 1733239, 1733240, 1733251, 1733262, 1733273, 1733284, 1733295, 1733307, 1733318, 1733329
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1161142002, 1161142006, 1161142010
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 035992, 448419, 588212
Country: FR Base de données publique des médicaments Identifier(s): 61970183, 67061971, 69279221
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 343642, 344870, 344874
Country: HK Department of Health Drug Office Identifier(s): 65657, 65658, 65659
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8104, 8121, 8122
Country: JP 医薬品医療機器総合機構 Identifier(s): 3999443A1025, 3999443A2021, 3999443A3028, 3999443G1028, 3999443G2024, 3999443G3020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1081609, 1081610, 1081611, 1081612, 1081613, 1081614, 1081615, 1081616, 1081617, 1081618, 1081619, 1081620
Country: NL Z-Index G-Standaard, PRK Identifier(s): 137480, 137499, 137502
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100381915, 100381921, 100381938
Country: SG Health Sciences Authority Identifier(s): 15450P, 15451P, 15452P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699862770033, 8699862770040, 8699862770057, 8699862770064, 8699862770071, 8699862770088, 8699862770095, 8699862770101, 8699862770118
Country: US FDA, National Drug Code Identifier(s): 55513-740, 55513-741, 55513-742

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.